Editorial: Overcoming Consumer Challenges in Sunscreen Selection

Main Article Content

Alex M Glazer
Division of Dermatology, University of Arizona, Tucson, AZ

Ryan M Svoboda
National Society for Cutaneous Medicine, New York, NY

Rebeca W Teplitz
New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY

Darrell S Rigel
Ronald O. Perelman Department of Dermatology, NYU School of Medicine, New York, NY

Keywords

sunscreen, SPF, recommendations, photoprotection, patient safety, safety

Abstract

Abstract not available

References

1. Svoboda RM, Teplitz RW, Farberg AS, Rigel DS. Patient and consumer knowledge of sunscreen labeling terminology: a cross-sectional survey. Manuscript in preparation.

2. EWG’s Guide to Sunscreens http://www.ewg.org/sunscreen/ accessed June 17, 2017.

3. Kroll D. “The Failure of Jessica Alba’s Honest Sunscreen Explained”. Forbes. August 3 2015. https://www.forbes.com/sites/davidkroll/2015/08/03/the-failure-of-jessica-albas-honest-company-sunscreen-explained/#57c2df8d3483. Accessed June 19 2017.

4. Wang SQ, Burnett ME, Lim HW. Safety of oxybenzone: putting numbers into perspective. Arch Dermatol. 2011;147(7):865-866.
5. Wang SQ, Douza SW, Lim HW. Safety of retinyl palmitate in sunscreens: a critical analysis. J Am Acad Dermatol. 2011;63(5):903-906.

6. Williams JD, Maitra P, Atillasoy E, Wu MM, Farberg AS, Rigel DS. SPF 100+ sunscreen is more protective against sunburn than SPF 50+ in actual-use: Results of a randomized, double-blind, split-face, natural sunlight exposure, clinical trial. J Am Acad Dermatol. 2017.

7. Ou-Yang H, Stanfield J, Cole C, Appa Y, Rigel D. High-SPF sunscreens (SPF >/= 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts. J Am Acad Dermatol. 2012;67(6):1220-1227.

8. Consumer Reports Sunscreen Buying Guide http://www.consumerreports.org/cro/sunscreens/buying-guide.htm accessed June 17, 2017.

9. Why some people worry that sunscreen might be bad for you Popular Science http://www.popsci.com/sunscreen-harmful accessed June 14, 2017.

10. Cole C, Appa Y, Ou-Yang H. A broad spectrum high-SPF photostable sunscreen with high UVA-PF can protect against cellular damage at high UV exposure doses. Photodermatol Photoimmunol Photomed. 2014;30(4):212-219.



11. Liebel F, Kaur S, Ruvolo E, et al. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. J Invest Dermatol. 2012;132(7):1901-1907.

12. Seité S, Moyal D, Verdier MP, et al. Accumulated p53 protein and UVA protection level of sunscreens. Photodermatol Photoimmunol Photomed. 2000;16(1):3-9.

13. Mancuso JB, Maruthi R, Wang SQ, et al. Sunscreens: an update. Am J Clin Dermatol. 2017; May 16. doi: 10.1007/s40257-017-0290-0. [Epub ahead of print]

14. Green AC, Williams GM, Logan V, et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29(3):257-263.

15. Olsen CM, Wilson LF, Green AC, et al. Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use. Aust N Z J Public Health. 2015;39(4):471-476.

16. Ghiasvand R, Weiderpass E, Green AC, et al. Sunscreen use and subsequent melanoma risk: a population-based cohort study. J Clin Oncol. 2016; Sep 12. Doi: 10.1200/JCO.2016.67.5934 [Epub ahead of print]

17. Olsen CM, Wilson LF, Green AC, Biswas N, Loyalka J, Whiteman DC. How many melanomas might be prevented if more people applied sunscreen regularly? British J Dermatol. 2018;178(1):140-147.

Article Sidebar

Full Article PDF
Published
Apr 30, 2018
DOI https://doi.org/10.25251/skin.2.3.3

Article Details

How to Cite
Glazer, A. M., Svoboda, R. M., Teplitz, R. W., & Rigel, D. S. (2018). Editorial: Overcoming Consumer Challenges in Sunscreen Selection. SKIN The Journal of Cutaneous Medicine, 2(3), 168–171. https://doi.org/10.25251/skin.2.3.3
Issue
Vol. 2 No. 3 (2018)
Section
Special Section on Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 > >>